Drugs & medicalClass II

Aurobindo Pharma USA Inc recalls Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only,…

cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

Read the official notice →
Date
2024-12-11
Country
United States
Brand
Aurobindo Pharma
Product
Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only,…
Classification
Class II
Units
USA Nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Aurobindo Pharma recalls

  1. 2026-08-12
  2. US
  3. 2025-06-25
  4. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc recalls Acetaminophen Tablets, 325 mg, 100-count bottles, Distributed by: Amazon.com Services LLC, 410 Terry Avenue N., Seattle, WA 98109, NDC…

    cGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).

    FDA · DrugAurobindo Pharma USA IncUSA Nationwide.Official notice →
  5. 2024-12-25
  6. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc recalls Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East…

    CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.

    FDA · DrugAurobindo Pharma USA IncNationwide in the USAOfficial notice →
  7. 2024-08-28
  8. US
    Drugs & medicalClass I

    Aurobindo Pharma USA Inc recalls Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles, Distributed by:…

    Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

    FDA · DrugAurobindo Pharma USA IncNJ, NY & PAOfficial notice →
  9. 2024-05-15
  10. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01, b) 500 tablets per bottle, NDC…

    Discoloration: Dotted and yellow spots on tablets

    FDA · DrugAurobindo Pharma USA Inc.Nationwide in the USAOfficial notice →
  11. 2023-09-27
  12. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A., NDC 0378-1270-93

    Failed dissolution specifications - results obtained were below spec average.

    FDA · DrugAurobindo Pharma USA Inc.USA nationwideOfficial notice →
All 15 Aurobindo Pharma recalls →

Other drugs & medical recalls in the United States

  1. 2024-12-11
  2. US
    Drugs & medicalClass II

    Midlab Incorporated recalls ROYALAB Germ Away Antibacterial Hand Soap, Chloroxylenol 0.1%, NET CONTENTS: ONE U.S. GALLON (3.78 L), Royal Papers, 2701 Hereford St.,…

    cGMP Deviations: Out of specification results for micro in hand soap products.

    FDA · DrugMidlab IncorporatedNationwide in the USAOfficial notice →
  3. US
    Drugs & medicalClass I

    Boulla LLC recalls ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zapmax.com

    Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

    FDA · DrugBoulla LLCNationwide within the United StatesOfficial notice →
  4. US
    Drugs & medicalClass II

    American Regent, Inc. recalls Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use…

    Presence of Particulate Matter: Potential for glass delamination from the vials.

    FDA · DrugAmerican Regent, Inc.Nationwide in the USAOfficial notice →
  5. US
  6. 2024-12-04
  7. US
    Drugs & medicalClass II

    Micro-X Ltd. recalls MICRO-X Rover Mobile X-ray System, # MXU-RV35

    Mobile x-ray system receiving/storage(operation) requirements to be followed: Temp:14 to 131(50 to 86) degrees F, RH:10% to 86%(30% to 60%) allow condensation dry time, Atmospheric Pressure:50kPa to 106 kPa(70kPa to…

    FDA · DeviceMicro-X Ltd.US: TX, PR, MD, CAOfficial notice →
  8. US
    Drugs & medicalClass II

    Gauthier Biomedical, Inc. recalls TriALTIS TORQUE LIMITER, RATCHET, 11.3 Nm, Model Number 5161-00-5048 (G919509)

    An out of specification component may result in the device exhibiting torque output higher than the design specification.

    FDA · DeviceGauthier Biomedical, Inc.US Nationwide distribution in the state of MA.Official notice →
See all drugs & medical recalls →